Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers

Published:2017-04 Issue:4 Volume:31 Page:576-590.e8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Hydbring Per,Wang Yinan,Fassl Anne,Li Xiaoting,Matia Veronica,Otto Tobias,Choi Yoon Jong,Sweeney Katharine E.,Suski Jan M.,Yin Hao,Bogorad Roman L.,Goel Shom,Yuzugullu Haluk,Kauffman Kevin J.,Yang Junghoon,Jin Chong,Li Yingxiang,Floris Davide,Swanson Richard,Ng Kimmie,Sicinska Ewa,Anders Lars,Zhao Jean J.,Polyak Kornelia,Anderson Daniel G.,Li Cheng,Sicinski Piotr

Funder

NIH

Wennergren Foundations

Peking-Tsinghua Center for Life Sciences

National Natural Science Foundation of China

MNISW Fellowship Mobilność Plus

Novartis

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference37 articles.

1. Aberrant regulation and function of microRNAs in cancer;Adams;Curr. Biol.,2014

2. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015

3. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1;Barbie;Nature,2009

4. MicroRNAs: target recognition and regulatory functions;Bartel;Cell,2009

5. The landscape of somatic copy-number alteration across human cancers;Beroukhim;Nature,2010

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death;Oncotarget;2024-07-12

2. MicroRNA-3653-3p inhibited papillary thyroid carcinoma progression by regulating CRIPTO-1;Cellular and Molecular Biology;2023-12-20

3. The tumor suppressor 5A2, a synthetic miR-7-5p mimic, targets oncogenic and metabolic pathways, as revealed by transcriptome-wide analysis;Frontiers in Drug Discovery;2023-07-07

4. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition;International Journal of Molecular Sciences;2023-05-18

5. JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis;Clinical and Translational Oncology;2023-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3